ArticleClinical epigenetics2026
Diet intervention altered DNA methylation of potassium voltage-gated channel subfamily Q member 1 in metabolic dysfunction-associated steatohepatitis.
Article in Clinical epigenetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundLifestyle interventions are cornerstones of metabolic dysfunction-associated fatty liver disease (MASLD) management, and differential DNA methylation of potassium voltage-gated channel subfamily Q member 1 (KCNQ1) was involved in MASLD-related diseases. However, little is known about the DNA methylation mechanism of KCNQ1 underlying the effect of lifestyle interventions on the most common liver disease.
objectiveThis study aimed to investigate the role of DNA methylation of KCNQ1 in metabolic dysfunction-associated steatohepatitis (MASH) after diet intervention.
methodsThis study utilized 38 male C57BL/6 mice (9-week-old, SPF grade). Following a 1-week acclimatization period, animals were randomly allocated to receive either a methionine-choline deficient (MCD, n = 23) or methionine-choline sufficient (MCS, n = 15) dietary regimen for 4 weeks. Seven mice per group were subsequently euthanized for MASH model validation. After confirming successful model establishment, remaining MASH mice underwent randomized allocation to four-week interventions: low-fat diet (LFD, n = 8), continued MCD feeding (n = 8), or control MCS maintenance (n = 8). Genomic DNA methylation patterns in hepatic and adipose tissues were analyzed using methylation-sensitive restriction enzyme sequencing (MethylRAD). For LFD-treated MASH specimens, EpiTYPER mass spectrometry and quantitative reverse transcription PCR were employed to assess DNA methylation status and transcriptional expression of KCNQ1, respectively.
resultsHypermethylation in the intron of KCNQ1 was observed after LFD intervention in the liver and adipose tissue of MASH mice (p < 0.05) with MethylRAD sequencing. High DNA methylation and low mRNA expression of KCNQ1 were validated in adipose tissue of MASH mice in response to LFD (p < 0.05) with the EpiTYPER array.
conclusionsThe study reinforced the role of DNA methylation in regulating gene expression of KCNQ1 in response to LFD intervention and highlighted that the DNA methylation of KCNQ1 in MASH adipose tissue could be tissue-specific. All these results contribute to elucidating the molecular mechanisms underlying the activities of DNA methylation in MASH.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.